InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (5 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Wedell-Wedellsborg Johan, Director. Director active across 1 company, notably Y-mAbs Therapeutics, Inc.. In total, 14 disclosures have been recorded. Split: 5 buys · 5 sells. Total volume traded: €6.5m. Activity tracked since 28 May 2021. The latest transaction was disclosed on 16 September 2025 (U). Regulator: SEC (Form 4). All data is free.
Declarations14 total
5,825 shares@ US$8.60Common StockSEC:0001753185-25-000004:0
25,080 shares0Common StockSEC:0001415889-25-019048:0
3,495 shares0Common StockSEC:0001104659-24-071401:0
6,455 shares@ US$6.85230.4% of flowCommon StockSEC:0001104659-23-125199:0
Ideal exit: 6 Sept 2024 (T+270)
6,183 shares@ US$6.500.3% of flowCommon StockSEC:0001104659-23-125054:0
Ideal exit: 2 Sept 2024 (T+270)
51,837 shares@ US$5.97022.5% of flowCommon StockSEC:0001104659-23-122895:0
Ideal exit: 25 Aug 2024 (T+270)
62,516 shares@ US$5.48692.8% of flowCommon StockSEC:0001104659-23-122095:0
Ideal exit: 23 Aug 2024 (T+270)
2,330 shares0Common StockSEC:0001104659-23-070045:0
101,740 shares@ US$9.64627.9% of flowCommon StockSEC:0001104659-23-061940:0
Ideal exit: 9 Feb 2024 (T+270)
11,229 shares@ US$36.15383.4% of flowCommon StockSEC:0001104659-21-080236:0
33,300 shares@ US$35.27619.8% of flowCommon StockSEC:0001104659-21-079592:0
72,400 shares@ US$34.151720.6% of flowCommon StockSEC:0001104659-21-078949:0
30,666 shares@ US$33.18568.5% of flowCommon StockSEC:0001104659-21-077703:0
25,000 shares@ US$36.3397.6% of flowCommon StockSEC:0001104659-21-075782:0
14 of 14 declarations
About Wedell-Wedellsborg Johan
Johan Wedell-Wedellsborg is a Director at Y-mAbs Therapeutics, Inc. He plays a key role in overseeing the company's activities and strategic direction. His expertise in the biotechnology field allows him to contribute to the innovation and growth of the company.
